The Trump administration is in negotiations with pharmaceutical companies Novo Nordisk and Eli Lilly to offer weight loss drugs at reduced prices through TrumpRx . According to sources familiar with the talks, the agreement could see a month's supply of these drugs priced at approximately $149, potentially benefiting some Medicare beneficiaries. Novo Nordisk produces the popular weight loss drug Wegovy, while Eli Lilly manufactures Zepbound.

The discussions, which are still ongoing, could lead to an official announcement soon. White House deputy press secretary Kush Desai stated that any discussions about unannounced deals should be viewed as speculative. However, press secretary Karoline Leavitt emphasized President Trump's commitment to reducing drug prices in the U.S.

Novo Nordi

See Full Page